Actionable news
0
All posts from Actionable news
Actionable news in CI: CIGNA CORPORATION,

Prospectuses and communications, business combinations

BGCOLOR="WHITE">

Filed by Anthem, Inc.

(Commission File No. 001-16751) pursuant

to Rule 425 under the Securities Act of

1933 and deemed filed pursuant to

Rule 14a-6(b) under the Securities Exchange

Act of 1934

Subject Company: Cigna Corporation

Commission File No. 001-08323

Commission File No. for Registration Statement on

Form S-4 filed by Anthem, Inc.: 333-207218

ANTHEM ANNOUNCES SPECIAL SHAREHOLDER MEETING WILL BE

HELD DECEMBER 3, 2015

Indianapolis, Ind. Oct. 28, 2015 Anthem, Inc. (NYSE: ANTM) today announced it will hold a special meeting of shareholders on Thursday, December 3, 2015 to approve the issuance of Anthem common stock, par value $0.01 per share, to Cigna Corporation (NYSE: CI) shareholders in connection with Anthems pending acquisition of Cigna and to approve the adjournment of the special meeting, if necessary, to solicit additional proxies. The special meeting of Anthem shareholders will be held at 8:00 a.m. Eastern Standard Time (EST) at the Conrad Hotel at 50 West Washington Street, Indianapolis, Indiana. Anthem shareholders of record at the close of business on October 22, 2015 will be entitled to vote at the special meeting.

About Anthem, Inc.

Anthem is working to transform health care with trusted and caring solutions. Our health plan companies deliver quality products and services that give their members access to the care they need. With over 72 million people served by its affiliated companies, including more than 38 million enrolled in its family of health plans, Anthem is one of the nations leading health benefits companies. For more information about Anthems family of companies, please visit www.antheminc.com/companies .

Important Information for Investors and Shareholders

This communication does not constitute an offer to sell or a solicitation of an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.

The proposed transaction between Anthem, Inc. (Anthem) and Cigna Corporation (Cigna) will be submitted to Anthems and Cignas shareholders for their consideration. In connection with the transaction, Anthem has filed with the U.S. Securities and Exchange Commission (the SEC) a registration statement on Form S-4, including Amendment No. 1 thereto, containing a joint proxy statement of Anthem and Cigna that also constitutes a prospectus of Anthem. The registration statement was declared effective by the SEC on October 26, 2015. Each of Anthem and Cigna will commence mailing the definitive joint proxy statement/prospectus to its shareholders on or about October 28, 2015. This communication is not a substitute for the registration statement, definitive joint proxy statement/prospectus or any other document that Anthem and/or Cigna have filed or may file with the SEC in connection with the proposed transaction.

INVESTORS AND SECURITY HOLDERS OF ANTHEM AND CIGNA ARE URGED TO READ THE DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY AS THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders may obtain free copies of the registration statement containing the definitive joint proxy statement/prospectus and other documents filed with the SEC by Anthem or Cigna through the web site maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Anthem are available free of charge on Anthems internet website at http://www.antheminc.com or by contacting Anthems Investor Relations Department at (317) 488-6390. Copies of the documents filed with the SEC by Cigna are available free of charge on Cignas internet website at...


More